» Articles » PMID: 25142477

Microvascular Disease in Chronic Thromboembolic Pulmonary Hypertension: a Role for Pulmonary Veins and Systemic Vasculature

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2014 Aug 22
PMID 25142477
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Limited numbers of operated patients with chronic thromboembolic pulmonary hypertension (CTEPH) are refractory to pulmonary endarterectomy (PEA) and experience persistent pulmonary hypertension (PH). We retrospectively assessed lung histology available from nine patients with persistent PH (ineffective PEA (inPEA) group) and from eight patients transplanted for distal CTEPH inaccessible by PEA (noPEA group). Microscopically observed peculiarities were compared with the histology of a recently developed CTEPH model in piglets. Pre-interventional clinical/haemodynamic data and medical history of patients from the inPEA and noPEA groups were collected and analysed. Conspicuous remodelling of small pulmonary arteries/arterioles, septal veins and pre-septal venules, including focal capillary haemangiomatosis, as well as pronounced hypertrophy and enlargement of bronchial systemic vessels, were the predominant pattern in histology from both groups. Most findings were reproduced in our porcine CTEPH model. Ink injection experiments unmasked abundant venular involvement in so-called small vessel or microvascular disease, as well as post-capillary bronchopulmonary shunting in human and experimental CTEPH. Microvascular disease is partly due to post-capillary remodelling in human and experimental CTEPH and appears to be related to bronchial-to-pulmonary venous shunting. Further studies are needed to clinically assess the functional importance of this finding.

Citing Articles

The Complex Spectrum of Chronic Thromboembolic Pulmonary Disease and the Implications of Hemodynamic Reclassification.

Risbano M, Risbano M Ann Am Thorac Soc. 2025; 22(3):324-326.

PMID: 39835967 PMC: 11892657. DOI: 10.1513/AnnalsATS.202412-1259ED.


Molecular Pathophysiology of Chronic Thromboembolic Pulmonary Hypertension: A Clinical Update from a Basic Research Perspective.

Gonzalez-Hermosillo L, Cueto-Robledo G, Navarro-Vergara D, Torres-Rojas M, Garcia-Cesar M, Perez-Mendez O Adv Respir Med. 2024; 92(6):485-503.

PMID: 39727495 PMC: 11673787. DOI: 10.3390/arm92060044.


From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiological Approach.

Shahidi P, Mentzel L, Blazek S, Sulimov D, Thiele H, Fengler K Rev Cardiovasc Med. 2024; 25(11):402.

PMID: 39618872 PMC: 11607516. DOI: 10.31083/j.rcm2511402.


The relationship between mixed venous blood oxygen saturation and pulmonary arterial and venous pressures in patients with heart failure.

Funaki R, Ogawa K, Mashitani Y, Oh T, Kashiwagi Y, Tanaka T Physiol Rep. 2024; 12(22):e70128.

PMID: 39567192 PMC: 11578653. DOI: 10.14814/phy2.70128.


Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy.

Feriel B, Alessandra C, Deborah G, Corinne N, Raphael T, Mina O Sci Rep. 2024; 14(1):28308.

PMID: 39550495 PMC: 11569243. DOI: 10.1038/s41598-024-79623-5.